{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:51:33Z","timestamp":1790088693666,"version":"4.0.1"},"reference-count":28,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV\u2010019330"],"award-info":[{"award-number":["INV\u2010019330"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rapid and robust strategies to evaluate the efficacy and effectiveness of novel and existing pharmacotherapeutic interventions (repurposed treatments) in future pandemics are required. Observational \u201creal\u2010world studies\u201d (RWS) can report more quickly than randomized controlled trials (RCTs) and would have value were they to yield reliable results. Both RCTs and RWS were deployed during the coronavirus disease 2019 (COVID\u201019) pandemic. Comparing results between them offers a unique opportunity to determine the potential value and contribution of each. A learning review of these parallel evidence channels in COVID\u201019, based on quantitative modeling, can help improve speed and reliability in the evaluation of repurposed therapeutics in a future pandemic. Analysis of all\u2010cause mortality data from 249 observational RWS and RCTs across eight treatment regimens for COVID\u201019 showed that RWS yield more heterogeneous results, and generally overestimate the effect size subsequently seen in RCTs. This is explained in part by a few study factors: the presence of RWS that are imbalanced for age, gender, and disease severity, and those reporting mortality at 2\u2009weeks or less. Smaller studies of either type contributed negligibly. Analysis of evidence generated sequentially during the pandemic indicated that larger RCTs drive our ability to make conclusive decisions regarding clinical benefit of each treatment, with limited inference drawn from RWS. These results suggest that when evaluating therapies in future pandemics, (1) large RCTs, especially platform studies, be deployed early; (2) any RWS should be large and should have adequate matching of known confounders and long follow\u2010up; (3) reporting standards and data standards for primary\u00a0endpoints, explanatory factors, and key subgroups should be improved; in addition, (4) appropriate incentives should be in place to enable access to patient\u2010level data; and (5) an overall aggregate view of all available results should be available at any given time.<\/jats:p>","DOI":"10.1111\/cts.13591","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T12:24:13Z","timestamp":1689769453000},"page":"1842-1855","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Totality of evidence of the effectiveness of repurposed therapies for <scp>COVID<\/scp>\u201019: Can we use <scp>real\u2010world<\/scp> studies alongside randomized controlled trials?"],"prefix":"10.1111","volume":"16","author":[{"given":"Jaap","family":"Mandema","sequence":"first","affiliation":[{"name":"Certara  Princeton New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Montgomery","sequence":"additional","affiliation":[{"name":"UCL  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Dron","sequence":"additional","affiliation":[{"name":"Cytel  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-3030","authenticated-orcid":false,"given":"Shuai","family":"Fu","sequence":"additional","affiliation":[{"name":"Certara  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Russek\u2010Cohen","sequence":"additional","affiliation":[{"name":"ERCStatLLC  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bromley","sequence":"additional","affiliation":[{"name":"Oyanalytika, Inc.  Potomac Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-6654","authenticated-orcid":false,"given":"Samer","family":"Mouksassi","sequence":"additional","affiliation":[{"name":"Certara  Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lalonde","sequence":"additional","affiliation":[{"name":"Lilly  Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7179-9049","authenticated-orcid":false,"given":"Aaron","family":"Springford","sequence":"additional","affiliation":[{"name":"Cytel  Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-2100","authenticated-orcid":false,"given":"Larry","family":"Tsai","sequence":"additional","affiliation":[{"name":"Genentech  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Ambery","sequence":"additional","affiliation":[{"name":"AstraZeneca  Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"McNair","sequence":"additional","affiliation":[{"name":"Bill and Melinda Gates Foundation  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawab","family":"Qizilbash","sequence":"additional","affiliation":[{"name":"OXON Epidemiology  Madrid Spain"},{"name":"London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Pocock","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-2260","authenticated-orcid":false,"given":"N\u00e9vine","family":"Zariffa","sequence":"additional","affiliation":[{"name":"NMD Group Inc.  Bala Cynwyd Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05965-4"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2185"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01501-9"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1901642"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106625"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.2196\/26718"},{"issue":"11","key":"e_1_2_11_9_1","article-title":"Interventions for the prevention and treatment of COVID\u201019: a living mapping of research and living network meta\u2010analysis","author":"Boutron I","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106239"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30542-8"},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069400","article-title":"Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir\u2010ritonavir, or dexamethasone for covid\u201019: meta\u2010epidemiological study","volume":"377","author":"Moneer O","year":"2022","journal-title":"BMJ"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.9151"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.256"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2014.0106"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-21416-0"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0805-y"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051718"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24136.1"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-021-00731-2"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00573-0"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-020-00766-2"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.21-0482"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","unstructured":"WiltzJL FeehanAK MolinariN et al.Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID\u201019\u2010United States March 2020\u2013August 2021. Accessed September 22 2022.https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7103e1.htm","DOI":"10.15585\/mmwr.mm7103e1"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0873"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05104-z"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05787-4"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-020-00250-z"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01434-3"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T07:32:29Z","timestamp":1697614349000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.13591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/cts.13591"],"URL":"https:\/\/doi.org\/10.1111\/cts.13591","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"2023-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}